WallStSmart

Kenvue Inc. (KVUE)vsUnited-Guardian Inc (UG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 139724% more annual revenue ($15.29B vs $10.94M). UG leads profitability with a 21.6% profit margin vs 10.6%. UG appears more attractively valued with a PEG of 1.13. UG earns a higher WallStSmart Score of 71/100 (B).

KVUE

Strong Buy

68

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 4.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.22

UG

Strong Buy

71

out of 100

Grade: B

Growth: 6.7Profit: 8.0Value: 8.0Quality: 7.3
Piotroski: 3/9Altman Z: 7.08
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-87.1%)

Margin of Safety

-87.1%

Fair Value

$9.91

Current Price

$17.71

$7.80 premium

UndervaluedFair: $9.91Overvalued
UGUndervalued (+36.2%)

Margin of Safety

+36.2%

Fair Value

$10.33

Current Price

$6.99

$3.34 discount

UndervaluedFair: $10.33Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE2 strengths · Avg: 8.0/10
Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

EPS GrowthGrowth
46.9%8/10

Earnings expanding 46.9% YoY

UG6 strengths · Avg: 8.5/10
Altman Z-ScoreHealth
7.0810/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
21.6%9/10

Keeps 22 of every $100 in revenue as profit

P/E RatioValuation
13.5x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.4%8/10

Strong operational efficiency at 22.4%

Revenue GrowthGrowth
15.8%8/10

15.8% revenue growth

Areas to Watch

KVUE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

UG2 concerns · Avg: 3.0/10
Market CapQuality
$32.25M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

The strongest argument for KVUE centers on Operating Margin, EPS Growth. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bull Case : UG

The strongest argument for UG centers on Altman Z-Score, Profit Margin, P/E Ratio. Profitability is solid with margins at 21.6% and operating margin at 22.4%. Revenue growth of 15.8% demonstrates continued momentum.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Altman Z-Score.

Bear Case : UG

The primary concerns for UG are Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

KVUE profiles as a value stock while UG is a growth play — different risk/reward profiles.

UG carries more volatility with a beta of 0.97 — expect wider price swings.

UG is growing revenue faster at 15.8% — sustainability is the question.

KVUE generates stronger free cash flow (350M), providing more financial flexibility.

Bottom Line

UG scores higher overall (71/100 vs 68/100), backed by strong 21.6% margins and 15.8% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

United-Guardian Inc

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. The company is headquartered in Hauppauge, New York.

Want to dig deeper into these stocks?